'Second-Generation' Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function

Neuropsychopharmacology

Volumn 40, Issue 6, 2015, Pages 1321-1331

  Saha, Kusumika ^a   Partilla, John S ^b   Lehner, Kurt R ^b   Seddik, Amir ^c   Stockner, Thomas ^a   Holy, Marion ^a   Sandtner, Walter ^a   Ecker, Gerhard F ^c   Sitte, Harald H ^a   Baumann, Michael H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4'-METHYL-ALPHA-PYRROLIDINOPROPIOPHENONE; 4-METHYLETHCATHINONE; AMPHETAMINE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; PROPIOPHENONE DERIVATIVE; PYRROLE DERIVATIVE; SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN TRANSPORTER;

ANIMAL; BRAIN; DRUG EFFECTS; HEK293 CELL LINE; HUMAN; MALE; METABOLISM; MOLECULAR DOCKING; MOTOR ACTIVITY; OOCYTE; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTOSOME; XENOPUS LAEVIS;

AMPHETAMINES; ANIMALS; BRAIN; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEK293 CELLS; HUMANS; MALE; MOLECULAR DOCKING SIMULATION; MOTOR ACTIVITY; OOCYTES; PROPIOPHENONES; PYRROLES; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES; XENOPUS LAEVIS;

EID: 84939961743     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.325     Document Type: Article

References (63)

1. Aarde SM, Angrish D, Barlow DJ, Wright MJ Jr, Vandewater SA, Creehan KM et al (2013a). Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol 18: 786-799.
2. Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013b). The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71: 130-140.
3. Adams SV, DeFelice LJ (2003). Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J 85: 1548-1559.
4. Andersen J, Olsen L, Hansen KB, Taboureau O, Jorgensen FS, Jorgensen AM et al (2010). Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter. J Biol Chem 285: 2051-2063.
5. Ayres TC, Bond JW (2012). A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs? BMJ Open 2: e000977.
6. Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF et al (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192-1203.
7. Baumann MH, Bulling S, Benaderet TS, Saha K, Ayestas MA, Partilla JS et al (2014). Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates. Neuropsychopharmacology 39: 1355-1365.
8. Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011). In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J Pharmacol Exp Ther 337: 218-225.
9. Baumann MH, Partilla JS, Lehner KR (2013a). Psychoactive "bath salts": not so soothing. Eur J Pharmacol 698: 1-5.
10. Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M et al (2013b). Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology 38: 552-562.
11. Blough BE, Landavazo A, Partilla JS, Baumann MH, Decker AM, Page KM et al (2014). Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics. ACS Med Chem Lett 5: 623-627.
12. Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS (2014). Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxy-pyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology 231: 199-207.
13. Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (2011). Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test Anal 3: 569-575.
14. Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ (2013). Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 168: 1750-1757.
15. Carroll FI, Blough BE, Mascarella SW, Navarro HA, Lukas RJ, Damaj MI (2014). Bupropion and bupropion analogs as treatments for CNS disorders. Adv Pharmacol 69: 177-216.
16. Cercato C, Roizenblatt VA, Leanca CC, Segal A, Lopes Filho AP, Mancini MC et al (2009). A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects. Int J Obes 33: 857-865.
17. Dargan PI, Sedefov R, Gallegos A, Wood DM (2011). The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 3: 454-463.
18. De Felice LJ, Glennon RA, Negus SS (2014). Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci 97: 20-26.
19. Drug Enforcement Administration (DEA), Department of Justice (2013). Establishment of drug codes for 26 substances. Final rule. Fed Regist 78: 664-666.
20. Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013). Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85: 1803-1815.
21. Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013). In vivo effects of abused 'bath salt' constituent 3,4-methylene-dioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38: 563-573.
22. Gatch MB, Taylor CM, Forster MJ (2013). Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones. Behav Pharmacol 24: 437-447.
23. Gil D, Adamowicz P, Skulska A, Tokarczyk B, Stanaszek R (2013). Analysis of 4-MEC in biological and non-biological material- three case reports. Forensic Sci Int 228: e11-e15.
24. Gobbi M, Funicello M, Gerstbrein K, Holy M, Moya PR, Sotomayor R et al (2008). N,N-dimethyl-thioamphetamine and methylthioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. J Neurochem 105: 1770-1780.
25. Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC et al (2011). 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339: 530-536.
26. Hofmaier T, Luf A, Seddik A, Stockner T, Holy M, Freissmuth M et al (2014). Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochem Int 73: 32-41.
27. Hou T, Wang J, Li Y, Wang W (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51: 69-82.
28. Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997). Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267: 727-748.
29. Jorgensen WL, Maxwell DS, Tirado Rives J (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118: 11225-11236.
30. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F et al (2011). Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164: 1949-1958.
31. Kolanos R, Solis E Jr, Sakloth F, De Felice LJ, Glennon RA (2013). "Deconstruction" of the abused synthetic cathinone methylene-dioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. ACS Chem Neurosci 4: 1524-1529.
32. Kristensen AS, Andersen J, Jorgensen TN, Sorensen L, Eriksen J, Loland CJ et al (2011). SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63: 585-640.
33. Leffler AM, Smith PB, de Armas A, Dorman FL (2014). The analytical investigation of synthetic street drugs containing cathinone analogs. Forensic Sci Int 234: 50-56.
34. Lewin AH, Seltzman HH, Carroll FI, Mascarella SW, Reddy PA (2014). Emergence and properties of spice and bath salts: a medicinal chemistry perspective. Life Sci 97: 9-19.
35. Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012). Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167: 407-420.
36. Marinetti LJ, Antonides HM (2013). Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 37: 135-146.
37. Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014). Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87: 206-213.
38. Marusich JA, Grant KR, Blough BE, Wiley JL (2012). Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice. Neurotoxicology 33: 1305-1313.
39. Meltzer PC, Butler D, Deschamps JR, Madras BK (2006). 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49: 1420-1432.
40. Penmatsa A, Wang KH, Gouaux E (2013). X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503: 85-90.
41. Rojek S, Klys M, Maciow-Glab M, Kula K, Strona M (2014). Cathinones derivatives-related deaths as exemplified by two fatal cases involving methcathinone with 4-methylmethcathinone and 4-methylethcathinone. Drug Test Anal 6: 770-777.
42. Rosenbaum CD, Carreiro SP, Babu KM (2012). Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8: 15-32.
43. Rothman RB, Baumann MH (2003). Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479: 23-40.
44. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M (1995). Evaluation of comparative protein modeling by MODELLER. Proteins 23: 318-326.
45. Scholze P, Zwach J, Kattinger A, Pifl C, Singer EA, Sitte HH (2000). Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter. J Pharmacol Exp Ther 293: 870-878.
46. Seddik A, Holy M, Weissensteiner R, Zdrazil B, Sitte HH, Ecker GF (2013). Probing the selectivity of monoamine transporter substrates by means of molecular modeling. Mol Inform 32: 409-413.
47. Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J et al (2013). Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168: 458-470.
48. Simmler LD, Rickli A, Hoener MC, Liechti ME (2014). Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79: 152-160.
49. Sitte HH, Freissmuth M (2010). The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters-why amphetamines take two to tango. J Neurochem 112: 340-355.
50. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998). Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71: 1289-1297.
51. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997). Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17: 960-974.
52. Spiller HA, Ryan ML, Weston RG, Jansen J (2011). Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol 49: 499-505.
53. Springer D, Fritschi G, Maurer HH (2003). Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-alpha-pyrrolidino-propiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 796: 253-266.
54. Springer D, Peters FT, Fritschi G, Maurer HH (2002). Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 773: 25-33.
55. Steinkellner T, Freissmuth M, Sitte HH, Montgomery T (2011). The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol Chem 392: 103-115.
56. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340: 249-258.
57. Thompson JD, Gibson TJ, Higgins DG (2002). Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2: Unit 2.3.
58. Wang H, Goehring A, Wang KH, Penmatsa A, Ressler R, Gouaux E (2013). Structural basis for action by diverse antidepressants on biogenic amine transporters. Nature 503: 141-145.
59. Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF et al (2014). Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19: 165-174.
60. Wilhelm BG, Mandad S, Truckenbrodt S, Krohnert K, Schafer C, Rammner B et al (2014). Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344: 1023-1028.
61. Wright MJ Jr, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM et al (2012). Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats. PLoS One 7: e44652.
62. Yu H, Rothman RB, Dersch CM, Partilla JS, Rice KC (2000). Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg Med Chem 8: 2689-2692.
63. Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V et al (2009). Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J Pharmacol Exp Ther 329: 738-746.